MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $698,000 | +4.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $671,000 | -73.4% | 10,000 | -67.4% | 0.00% | -66.7% |
| Q1 2022 | $2,520,000 | +68.7% | 30,637 | +200.8% | 0.00% | +50.0% |
| Q4 2021 | $1,494,000 | -15.5% | 10,186 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,769,000 | +9.5% | 10,186 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $1,616,000 | -9.7% | 10,002 | -4.3% | 0.00% | -33.3% |
| Q1 2021 | $1,790,000 | -59.3% | 10,452 | -47.7% | 0.00% | 0.0% |
| Q4 2020 | $4,394,000 | +15.4% | 20,002 | -40.0% | 0.00% | -62.5% |
| Q2 2020 | $3,809,000 | +48.6% | 33,361 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $2,564,000 | -67.0% | 33,361 | -44.7% | 0.01% | -60.0% |
| Q4 2019 | $7,765,000 | – | 60,286 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |